Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
During the last 30 years, the incidence of oesophagealadenocarcinoma has increased rapidly.
2
Methods: Consecutive patients with oesophagealadenocarcinoma who underwent PET-CT before neoadjuvant chemotherapy and resection were included.
3
Patients with Barrett's oesophagus have an increased risk of developing oesophagealadenocarcinoma and should be kept under surveillance.
4
There are few epidemiological data on the dietary risk factors of Barrett's oesophagus, a precursor of oesophagealadenocarcinoma.
5
The incidence of oesophagealadenocarcinoma (EADC) is rapidly increasing in Western countries and obesity is thought to be a major risk factor.
1
Incidence rates for adenocarcinomaoftheesophagus and gastric cardia have been rising rapidly.
2
Methods and materials: Patients with adenocarcinomaoftheesophagus without distant organ metastases were eligible.
3
Incidence increased for several cancers, including pancreas, kidney, and adenocarcinomaoftheesophagus, which are associated with excess weight.
4
Patients and methods: Sixty-one patients with advanced, surgically unresectable, or metastatic squamous cell or adenocarcinomaoftheesophagus were treated.
5
A retrospective analysis should compare the two operative approaches, transhiatal or transthoracic resection in patients suffering from adenocarcinomaoftheesophagus.
1
Barrett's esophagus is an important step in the pathway to esophagealadenocarcinoma.
2
Context: The incidence of esophagealadenocarcinoma is rising and has surpassed squamous cell carcinoma.
3
Future studies of trastuzumab in esophagealadenocarcinoma are indicated.
4
Barrett's esophagus (BE) is the principal risk factor for esophagealadenocarcinoma.
5
Barrett's esophagus is the precursor lesion for esophagealadenocarcinoma.